Literature DB >> 26629068

A rat model of liver transplantation with a steatotic donor liver after cardiac death.

Qiucheng Cai1, Hongkai Fan2, Rihui Xiong1, Yi Jiang3.   

Abstract

This study aimed to establish a rat liver transplantation model with a steatotic donor liver after cardiac death, reflecting clinical conditions. Rats were fed a high-fat diet for 8 weeks to establish the fatty liver model. This model simulates liver steatosis caused by various factors before clinical donation after cardiac death. A pneumothorax was created in the donor rat to induce hypoxia and cardiac arrest before incising the liver. This simulated the processes of hypoxia and cardiac arrest caused by withdrawal of treatment in actual clinical situations. The harvested cardiac death donor liver was then transplanted using the Kamada technique. Donor operative time was 45.7 ± 4.2 min; cardiac arrest time, 9 ± 0.8 min; recipient surgery time, 40.3 ± 4.9 min; and no-liver time, 15 ± 2.5 min. Of 40 liver-transplanted rats, 2 died within 24 h, with a surgical success rate of 95%. The transaminase levels on post-transplantation days 1, 3, 5, and 7 were 835.4 ± 71.33 U/L, 1334.5 ± 102.13 U/L, 536.4 ± 65.52 U/L, and 218.2 ± 36.77 U/L, respectively. This rat liver transplantation model with a steatotic donor liver after cardiac death could improve the simulation of the pathophysiological processes of clinical donation after cardiac death, and could be used as a reliable and stable animal model.

Entities:  

Keywords:  Rat; cardiac death; liver transplantation; steatosis

Year:  2015        PMID: 26629068      PMCID: PMC4658957     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Donation after cardiac death liver transplantation: time for policy to catch up with practice.

Authors:  Anton I Skaro; Edward Wang; Vadim Lyuksemburg; Michael Abecassis
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

2.  Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death.

Authors:  Yanjun Shi; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

3.  Donation after cardiac death and liver transplantation.

Authors:  Kenneth J Woodside
Journal:  J Surg Res       Date:  2012-07-07       Impact factor: 2.192

4.  The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.

Authors:  Austin L Spitzer; Oliver B Lao; André A S Dick; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Matthew M Yeh; Melissa P Upton; Jorge D Reyes; James D Perkins
Journal:  Liver Transpl       Date:  2010-07       Impact factor: 5.799

Review 5.  Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Yurie Soejima; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

Review 6.  Current status of donation after cardiac death liver transplantation.

Authors:  David J Reich; Johnny C Hong
Journal:  Curr Opin Organ Transplant       Date:  2010-06       Impact factor: 2.640

Review 7.  Animal models of nonalcoholic fatty liver disease and steatohepatitis.

Authors:  Amin A Nanji
Journal:  Clin Liver Dis       Date:  2004-08       Impact factor: 6.126

Review 8.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

9.  A surgical experience with five hundred thirty liver transplants in the rat.

Authors:  N Kamada; R Y Calne
Journal:  Surgery       Date:  1983-01       Impact factor: 3.982

10.  Orthotopic liver transplantation in rats.

Authors:  Graziano Oldani; Stephanie Lacotte; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  J Vis Exp       Date:  2012-07-01       Impact factor: 1.355

View more
  1 in total

1.  GSK-3β mediates ischemia-reperfusion injury by regulating autophagy in DCD liver allografts.

Authors:  Tingting Liu; Yang Han; Wu Lv; Pan Qi; Wenshi Liu; Ying Cheng; Jianan Yu; Yongfeng Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.